The New York Times dribbled out yet another turbo-cancer story yesterday, this one under the headline, “
Cancer’s New Face: Younger and Female.” The sub-headline explained, “Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report.” It never mentioned the jabs, so you can stop wondering right now.
Let us count the ways the New York Times conceals truth. Since the jab rollout in late 2020, corporate media and Big $cience have deceptively reported rising cancer rates —especially in unusual populations— by relying only on older data showing creeping cancer rates but
nothing more recent than 2019.
In other words,
see? it can’t be the jabs, dummies.
Of course, they only just recently became alarmed about
decades of slowly rising cancer rates through 2019 — in 2023. One suspects that the more recent numbers evidence a horrifying post-jab spike. Hence all the obfuscation. But they are
telling us about the increase in cancer sort of metaphorically.
No need to point the finger of blame, old boy.
They kept that silly game going through, but this article was different. At first, I thought it must be that, now we’re in 2025, readers might not so readily accept researchers cutting the cancer analysis off
six years ago. Indeed, when I read
the American Cancer Society report fueling the article, I noticed they’d finally advanced cancer data to 2022.
They’re far from current, but the lagging official cancer analysis is
overlapping the early jab period now.
Instead of making it obvious they were citing old data, the Times just didn’t cite
any time periods at all. “Certain cancers are turning up more often,” the Times said, but
how much more often? Since
when? The Grey Lady had no comment.
This strategic shift explains the brand-new bias toward young women. In the pre-2020 data, cancers were creeping up
evenly, across the board, without discriminating. For example,
a big Lancet study published last August using the pre-2020-data never mentioned any pro-woman bias, across 34 different types of cancer:
But now, six months later, cancers “which used to affect far more men than women,” the Times explained, are “striking young and middle-aged adults and women more frequently.”
If you read “young and middle-aged adults” as
college and working-age adults, it becomes obvious that phrase describes the population most likely to have gotten tangled up with a mRNA vaccine mandate. And, lest you decry cancer’s deplorable sexist bias toward the fairer gender, digging into the ACA report revealed that men of any race were far more likely to die from their cancers than the ladies, which sort of evens things out.
The Times apparently found men’s excess death rates to be so boring it was utterly unworthy of mention. At all.
Anyway,
of course the sold-out scientists interviewed for the story remain baffled, perplexed, and bewildered. They have no new ideas, even about the rising rates of
lung cancer and
mouth cancer despite the government’s thirty-year war on tobacco. What could cause nearly all cancers to sharply increase in previously unaffected age groups? Could it possibly be
environmental factors? Microplastics? Forever chemicals? Red dye number 3, just banned by the FDA?
The shots? Nope.
The Times rolled out a long, blamey laundry list of cancer self-causes including: eating too much red meat, eating too much everything, drinking too much, being lazy about cancer screenings, smoking too much, vaping too much, staying up too late, and, I am not making this up, waiting too long to have kids, due to hormonal shifts or something.
Science!
Never deny it.
The great thing for the Times about all those proposed “personal responsibility” causes is that they don’t offend any big industry partners or government regulators. Blaming it on
us doesn’t hurt
anybody’s bottom line.
Ironically, the Times ran a related story yesterday headlined, “
What to Know About the Ban on Red Dye No. 3 in Food.” It took activists
years to force the FDA to ban the oncogenic coloring chemical, erythrosine, through a citizen’s petition,
which the FDA resisted the whole time, even though erythrosine has been banned in topical cosmetics since 1990.
Why didn’t the Times take the glaringly obvious opportunity to connect the two related stories, even if only conceptually? But neither mentions the other, leaving it up to the reader to do the work.
Not only that, but only a few weeks ago another big study fueled many corporate media headlines,
like this one from Fortune:
The Times’ new cancer story did not mention this December study linking cancer to ultra-processed foods. (Actually, no Times headline has mentioned processed food since last July, while Kennedy was still a presidential candidate.)
So, even though environmental factors are a target-rich environment themselves, the Times mentioned none of these recent stories, relying only on the self-causes of cancer, with no logical explanation for why age-old lifestyle excuses like overeating and drinking too much should suddenly cause more cancer in young people
now.
More media messaging over spiking turbo cancer; Deep state rewrites history of Biden's involuntary departure; FBI's DEI office enters witness protection; Trump tax revolution quietly begins; more.
www.coffeeandcovid.com